Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 TrialVikram M. Narayan, Colin P. Dinney, Mehrdad Alemozaffar et al.|The Journal of Urology|2024Cited by 80